Quality of life in inflammatory bowel diseases: it is not all about the bowel

Background/Aims The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving Q...

Full description

Bibliographic Details
Main Authors: Ronald Keller, Nazar Mazurak, Laura Fantasia, Stefano Fusco, Nisar P Malek, Jan Wehkamp, Paul Enck, Thomas Klag
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-01-01
Series:Intestinal Research
Subjects:
Online Access:http://www.irjournal.org/upload/pdf/ir-2019-00135.pdf
id doaj-cee0bffdd97b4e2d95e1c62e0142fec9
record_format Article
spelling doaj-cee0bffdd97b4e2d95e1c62e0142fec92021-02-09T06:02:16ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562021-01-01191455210.5217/ir.2019.00135818Quality of life in inflammatory bowel diseases: it is not all about the bowelRonald Keller0Nazar Mazurak1Laura Fantasia2Stefano Fusco3Nisar P Malek4Jan Wehkamp5Paul Enck6Thomas Klag7 Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany Division of Psychosomatic Medicine and Psychotherapy, Department of Internal Medicine VI, University Hospital Tübingen, Tübingen, Germany Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany Division of Psychosomatic Medicine and Psychotherapy, Department of Internal Medicine VI, University Hospital Tübingen, Tübingen, Germany Division of Gastroenterology, Hepatology, Infectious Diseases, Department of Internal Medicine I, University Hospital Tübingen, Tübingen, GermanyBackground/Aims The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving QUOL should be one of the main goals of therapy. This study aims to identify factors contributing to good or impaired QUOL. Methods Questionnaires addressing health-related QUOL and other psychological and social features were positioned on our institutions’ webpage and on the webpage of the largest self-help group for IBD in Germany. Patients were subdivided according to their QUOL score with a cutoff of <60. We used the Short Inflammatory Bowel Disease Questionnaire, the Assessment of the Demand for Additional Psychological Treatment, and the Fear of Progression Questionnaire Short Form. Results High numbers of patients in both subgroups showed an impaired QUOL (87.34% in UC, 91.08% in CD). Active extraintestinal manifestations, smoking, high fear of progression and high demand for psychotherapy were associated with reduced QUOL. In addition, polypharmacological interventions did not result in a good QUOL, but ostomies are linked to improved QUOL especially in CD patients. Conclusions Scores used in clinical day-to-day-practice mainly focusing on somatic factors do not sufficiently address important aspects concerning QUOL. Most importantly, extraintestinal manifestations show a hitherto underestimated impact on QUOL.http://www.irjournal.org/upload/pdf/ir-2019-00135.pdfquality of lifecrohn diseasecolitis, ulcerativeextraintestinal manifestations
collection DOAJ
language English
format Article
sources DOAJ
author Ronald Keller
Nazar Mazurak
Laura Fantasia
Stefano Fusco
Nisar P Malek
Jan Wehkamp
Paul Enck
Thomas Klag
spellingShingle Ronald Keller
Nazar Mazurak
Laura Fantasia
Stefano Fusco
Nisar P Malek
Jan Wehkamp
Paul Enck
Thomas Klag
Quality of life in inflammatory bowel diseases: it is not all about the bowel
Intestinal Research
quality of life
crohn disease
colitis, ulcerative
extraintestinal manifestations
author_facet Ronald Keller
Nazar Mazurak
Laura Fantasia
Stefano Fusco
Nisar P Malek
Jan Wehkamp
Paul Enck
Thomas Klag
author_sort Ronald Keller
title Quality of life in inflammatory bowel diseases: it is not all about the bowel
title_short Quality of life in inflammatory bowel diseases: it is not all about the bowel
title_full Quality of life in inflammatory bowel diseases: it is not all about the bowel
title_fullStr Quality of life in inflammatory bowel diseases: it is not all about the bowel
title_full_unstemmed Quality of life in inflammatory bowel diseases: it is not all about the bowel
title_sort quality of life in inflammatory bowel diseases: it is not all about the bowel
publisher Korean Association for the Study of Intestinal Diseases
series Intestinal Research
issn 1598-9100
2288-1956
publishDate 2021-01-01
description Background/Aims The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving QUOL should be one of the main goals of therapy. This study aims to identify factors contributing to good or impaired QUOL. Methods Questionnaires addressing health-related QUOL and other psychological and social features were positioned on our institutions’ webpage and on the webpage of the largest self-help group for IBD in Germany. Patients were subdivided according to their QUOL score with a cutoff of <60. We used the Short Inflammatory Bowel Disease Questionnaire, the Assessment of the Demand for Additional Psychological Treatment, and the Fear of Progression Questionnaire Short Form. Results High numbers of patients in both subgroups showed an impaired QUOL (87.34% in UC, 91.08% in CD). Active extraintestinal manifestations, smoking, high fear of progression and high demand for psychotherapy were associated with reduced QUOL. In addition, polypharmacological interventions did not result in a good QUOL, but ostomies are linked to improved QUOL especially in CD patients. Conclusions Scores used in clinical day-to-day-practice mainly focusing on somatic factors do not sufficiently address important aspects concerning QUOL. Most importantly, extraintestinal manifestations show a hitherto underestimated impact on QUOL.
topic quality of life
crohn disease
colitis, ulcerative
extraintestinal manifestations
url http://www.irjournal.org/upload/pdf/ir-2019-00135.pdf
work_keys_str_mv AT ronaldkeller qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT nazarmazurak qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT laurafantasia qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT stefanofusco qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT nisarpmalek qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT janwehkamp qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT paulenck qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
AT thomasklag qualityoflifeininflammatoryboweldiseasesitisnotallaboutthebowel
_version_ 1724277899617370112